/CTX.WA
CTX.WA Stock - Captor Therapeutics Spolka Akcyjna
Healthcare|BiotechnologyWSE
$69.80+2.65%
+$1.80 (+2.65%) • Dec 23
78
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.93
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $76.78
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CTX.WA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$69.10 – $70.50
TARGET (TP)$80.27
STOP LOSS$64.22
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.69
52W High$77.00
52W Low$31.20
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $15.82M | $13.20M | $9.16M | $3.99M | N/A |
| Gross Profit | $6.42M | $6.90M | $7.07M | $3.25M | $-6,602,000 |
| Gross Margin | 40.6% | 52.3% | 77.2% | 81.4% | N/A |
| Operating Income | $-44,760,000 | $-73,016,000 | $-38,364,000 | $-31,708,000 | $-12,216,000 |
| Net Income | $-38,426,000 | $-70,584,000 | $-35,894,000 | $-32,572,000 | $-13,087,000 |
| Net Margin | -242.8% | -534.7% | -391.9% | -817.2% | N/A |
| EPS | $-8.25 | $-15.19 | $-8.61 | $-7.89 | $-3.90 |
Company Overview
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has five projects at the preclinical stage. The company was incorporated in 2015 and is based in Wroclaw, Poland.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CTX.WABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-2.08
Q4 2025
EPS Surprise History
Q4 23
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 20, 2025 | — | $-2.08 | — | — |
Q2 2025 | May 27, 2025 | — | $-1.95 | — | — |
Q2 2025 | Apr 15, 2025 | — | $-1.59 | — | — |
Q4 2024 | Nov 8, 2024 | — | $-2.20 | — | — |
Q3 2024 | Sep 6, 2024 | — | $-2.14 | — | — |
Q2 2024 | May 30, 2024 | — | $-2.04 | — | — |
Q2 2024 | Apr 9, 2024 | — | $-2.47 | — | — |
Q4 2023 | Nov 28, 2023 | — | $-3.72 | — | — |
Q3 2023 | Sep 7, 2023 | — | $-6.91 | — | — |
Q2 2023 | May 30, 2023 | — | $-3.09 | — | — |
Q2 2023 | Apr 7, 2023 | — | $-1.16 | — | — |
Q4 2022 | Nov 24, 2022 | — | $-1.85 | — | — |
Q3 2022 | Sep 3, 2022 | — | $-2.36 | — | — |
Q2 2022 | May 2, 2022 | — | $-2.69 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-2.64 | — | — |
Q4 2021 | Nov 30, 2021 | — | $-2.15 | — | — |
Q4 2021 | Oct 1, 2021 | — | $-1.81 | — | — |
Q2 2021 | May 29, 2021 | — | $-1.64 | — | — |
Q2 2021 | May 2, 2021 | — | $-0.49 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-1.94 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CTX.WA
What is CTX.WA's current stock price?
Captor Therapeutics Spolka Akcyjna (CTX.WA) is currently trading at $69.80 per share. The stock has moved +2.65% today.
What is the analyst price target for CTX.WA?
No analyst price targets are currently available for this stock.
What sector is Captor Therapeutics Spolka Akcyjna in?
Captor Therapeutics Spolka Akcyjna operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the WSE exchange.
What is CTX.WA's market cap?
Captor Therapeutics Spolka Akcyjna has a market capitalization of $0.39 billion, making it a small-cap company.
Does CTX.WA pay dividends?
No, Captor Therapeutics Spolka Akcyjna does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBIO.WA
Bioton S.a.
$3.76
Mkt Cap: $0.3B
MAB.WA
Mabion S.A.
$6.95
Mkt Cap: $0.1B
MDG.WA
Medicalgorithmics S.A.
$34.00
Mkt Cap: $0.3B
MOC.WA
Molecure S.A.
$6.36
Mkt Cap: $0.1B
NNG.WA
NanoGroup S.A.
$2.60
Mkt Cap: $0.1B
PTG.WA
Poltreg S.A.
$24.60
Mkt Cap: $0.1B
PUR.WA
Pure Biologics Spólka Akcyjna
$3.70
Mkt Cap: $0.0B
RVU.WA
Ryvu Therapeutics S.A.
$25.35
Mkt Cap: $0.6B
SVE.WA
Synthaverse S.A.
$3.53
Mkt Cap: $0.2B
URT.WA
Urteste S.A.
$40.00
Mkt Cap: $0.1B
Explore stocks similar to CTX.WA for comparison